bosentan tablets

bosentan tablets
SPL v6
SPL
SPL Set ID 02892f47-0d59-4254-9ee7-d524278fdd79
Route
oral
Published
Effective Date 2023-09-20
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
bosentan anhydrous (62.5 mg)
Inactive Ingredients
ethylcellulose, unspecified ferric oxide red ferric oxide yellow glyceryl dibehenate hypromellose, unspecified magnesium stearate povidone sodium starch glycolate type a potato starch, corn talc titanium dioxide triacetin

Identifiers & Packaging

Pill Appearance
Imprint: 447 Shape: round Shape: oval Color: pink Size: 7 mm Size: 11 mm Score: 1
Marketing Status
anda active Since 2019-05-01

Description

NDC 70771-1017-6 Bosentan tablets, 62.5 mg 60 tablets Rx only NDC 70771-1018-6 Bosentan tablets, 125 mg 60 tablets Rx only


Medication Information

Description

NDC 70771-1017-6 Bosentan tablets, 62.5 mg 60 tablets Rx only NDC 70771-1018-6 Bosentan tablets, 125 mg 60 tablets Rx only

Package Label.principal Display Panel

NDC 70771-1017-6

Bosentan tablets, 62.5 mg

60 tablets

Rx only

NDC 70771-1018-6

Bosentan tablets, 125 mg

60 tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1017-6

Bosentan tablets, 62.5 mg

60 tablets

Rx only

NDC 70771-1018-6

Bosentan tablets, 125 mg

60 tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)